vimarsana.com

Latest Breaking News On - Paratek pharmaceuticals company profile - Page 1 : vimarsana.com

Paratek Pharmaceuticals, Inc (NASDAQ:PRTK) Position Reduced by Perkins Capital Management Inc

Perkins Capital Management Inc. lowered its position in shares of Paratek Pharmaceuticals, Inc. (NASDAQ:PRTK – Free Report) by 70.0% in the 2nd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 13,700 shares of the specialty pharmaceutical company’s stock after selling 32,000 shares during the quarter. Perkins […]

Paratek Pharmaceuticals (NASDAQ:PRTK) Earns Hold Rating from Analysts at StockNews com

StockNews.com assumed coverage on shares of Paratek Pharmaceuticals (NASDAQ:PRTK – Free Report) in a research report sent to investors on Monday. The brokerage issued a hold rating on the specialty pharmaceutical company’s stock. Several other equities analysts have also recently weighed in on PRTK. Jefferies Financial Group cut Paratek Pharmaceuticals from a buy rating to […]

StockNews com Begins Coverage on Paratek Pharmaceuticals (NASDAQ:PRTK)

StockNews.com started coverage on shares of Paratek Pharmaceuticals (NASDAQ:PRTK – Free Report) in a research report report published on Monday morning. The firm issued a hold rating on the specialty pharmaceutical company’s stock. Several other equities analysts also recently commented on PRTK. BTIG Research cut their price target on shares of Paratek Pharmaceuticals from $24.00 […]

Paratek Pharmaceuticals (NASDAQ:PRTK) Now Covered by Analysts at StockNews com

StockNews.com assumed coverage on shares of Paratek Pharmaceuticals (NASDAQ:PRTK – Free Report) in a research report sent to investors on Sunday morning. The firm issued a hold rating on the specialty pharmaceutical company’s stock. Several other equities research analysts have also weighed in on PRTK. HC Wainwright lowered Paratek Pharmaceuticals from a buy rating to […]

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.